Biotech Sage Therapeutics skyrockets more than 60% after depression drug breakthrough
December 07, 2017 at 09:03 AM EST
Sixty-four percent of patients achieved major depressive disorder remission using SAGE-217 in the 15th day of treatment, Sage Therapeutics said.